Menu

Global Blood Therapeutics, Inc. GBT

Full chart Compare
Set alert

Price alert · GBT

All alert types
68.49 +68.49

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $543.00KExpenses → Selling, General & Admin: $266.99MExpenses → Research & Development: $212.13MExpenses → Interest Expense: $15.47MExpenses → Income Tax: $477.00KGross Profit → Expenses: $191.43MRevenue → Gross Profit: $191.43MRevenue → Cost of Revenue: $3.32MNet Loss → Expenses: $303.09MOther Income$543.00KGross Profit$191.43MNet Loss$303.09MCost of Revenue$3.32MExpenses$495.07MSelling, General & Admin$266.99MResearch & Development$212.13MInterest Expense$15.47MIncome Tax$477.00KRevenue$194.75M

Latest period ending Dec 31, 2021 · select a line to chart its full history

Annual income statement

GBT annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
194.75M123.80M2.11M00
194.75M123.80M2.11M00
3.32M1.99M48.00K00
191.43M121.82M2.06M00
479.12M365.97M291.64M182.74M119.25M
212.13M155.12M174.56M131.31M87.81M
266.99M210.85M117.09M51.44M31.44M
-287.69M-244.16M-289.58M-182.74M-119.25M
15.47M9.81M894.00K346.00K0
477.00K04.00K00
-303.09M-247.55M-266.77M-174.19M-117.02M
-303.09M-247.55M-266.77M-174.19M-117.02M
-303.09M-247.55M-266.77M-174.19M-117.02M
-303.09M-247.55M-266.77M-174.19M-117.02M
-4.81-4.04-4.57-3.41-2.76
-4.81-4.04-4.57-3.41-2.76
-4.81-4.04-4.57-3.41-2.76
-287.15M-237.74M-265.87M-173.85M-117.02M
-287.15M-237.74M-265.87M-173.85M-117.02M
62.96M61.33M58.32M51.15M42.32M
62.96M61.33M58.32M51.15M42.32M